Phosphorylation of guanosine monophosphate reductase triggers a GTP-dependent switch from pro- to anti-oncogenic function of EPHA4 is a research paper published in Cell chemical biology (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Aging
Grant: AG062617
National Institutes of Health
Grant: GM054403
National Institutes of Health
Grant: AI125362
National Institutes of Health
Grant: CA264984
Comprehensive Cancer Center at Wake Forest Baptist Medical Center
Grant: P30CA012197
National Cancer Institute
Grant: P30CA16056
National Cancer Institute
Grant: CA247819
National Cancer Institute
Grant: CA224434
National Cancer Institute
Grant: CA248018
NIAID NIH HHS
Grant: R01 AI125362
NCI NIH HHS
Grant: R01 CA264984
NIGMS NIH HHS
Grant: R01 GM054403
NCI NIH HHS
Grant: R37 CA248018
NCI NIH HHS
Grant: T32 CA247819
NIA NIH HHS
Grant: R01 AG062617
NCI NIH HHS
Grant: R01 CA224434
NCI NIH HHS
Grant: P30 CA016056
Roswell Park Alliance Foundation, Roswell Park Cancer Institute
Roswell Park Cancer Institute
Comprehensive Cancer Center at Wake Forest Baptist Medical Center
MeSH Terms
Keywords
Additional file 1 of Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
Additional file 1 of Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
Additional file 2 of Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
Additional file 2 of Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
Additional file 4 of Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
Additional file 3 of Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
Additional file 4 of Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
Additional file 3 of Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma